FDA 510(k)

Onclarity™ Self-Collection Kit

N.º K: K260184 · 2026-04-02

SolicitanteBecton, Dickinson and Company

Fecha de decisión2026-04-02

Código de productoSEP

Comité asesorMI

DecisiónSubstantially Equivalent

Resumen del dispositivo

Onclarity™ Self-Collection Kit is the device name listed in this FDA 510(k) record. The listed applicant is Becton, Dickinson and Company. It received FDA 510(k) clearance on 2026-04-02 under 510(k) number K260184. The device is classified under product code SEP. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Preguntas frecuentes

What is the Onclarity™ Self-Collection Kit?

Onclarity™ Self-Collection Kit is a medical device that received FDA 510(k) clearance on 2026-04-02. The listed applicant is Becton, Dickinson and Company. The 510(k) number is K260184.

When did Onclarity™ Self-Collection Kit receive FDA 510(k) clearance?

Onclarity™ Self-Collection Kit received FDA 510(k) clearance on 2026-04-02, under 510(k) number K260184.

Who is the listed applicant for Onclarity™ Self-Collection Kit?

The FDA 510(k) record lists Becton, Dickinson and Company as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Onclarity™ Self-Collection Kit?

The FDA product code for Onclarity™ Self-Collection Kit is SEP.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Otros registros que enlistan a Becton, Dickinson and Company como solicitante

K262163BD BBL Mueller Hinton II Broth (Cation-Adjusted); BD Difco Mueller Hinton Broth K260128BD Preset™ and BD A-Line™ Arterial Blood Collection Syringes K252506BD Vacutainer® Safety-Lok™ Blood Collection Set; BD Vacutainer® Safety-Lok™ Blood Collection Set with Pre-Attached Holder K252378BD® MiniDraw™ Capillary Blood Collection System with BD® MiniDraw™ SST™ Capillary Blood Collection Tube K252040BD Vacutainer® Plasma Separator Tubes (PST™), BD Vacutainer® Sodium Heparin Blood Collection Tubes K250884Inyección de Cloruro de Sodio al 0.9 %, USP, Jeringa BD PosiFlush™ SP

Ver todos los 102 dispositivos →

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.